{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:19:26Z","timestamp":1760955566751},"reference-count":31,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea (NRF)","doi-asserted-by":"crossref","award":["NRF-2014R1A1A1002129"],"award-info":[{"award-number":["NRF-2014R1A1A1002129"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"crossref","award":["NRF-2014R1A2A2A01002576"],"award-info":[{"award-number":["NRF-2014R1A2A2A01002576"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Grant from Kangwon National University","award":["C1010931-01-01\/120140407"],"award-info":[{"award-number":["C1010931-01-01\/120140407"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.10.103","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T06:54:44Z","timestamp":1446620084000},"page":"6604-6610","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection"],"prefix":"10.1016","volume":"33","author":[{"given":"Young-In","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hyoung","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Eun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha-Neul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Duk","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KwiSung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SangWon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Gu","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Na","family":"Kweon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Jeong","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Young","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.10.103_bib0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jgr.2014.04.003","article-title":"Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and human rhinovirus 3","volume":"38","author":"Song","year":"2014","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4062\/biomolther.2013.108","article-title":"Antiviral activity of hederasaponin B from Hedera helix against Enterovirus 71 subgenotypes C3 and C4a","volume":"22","author":"Song","year":"2014","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0170","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/jmv.24018","article-title":"Characterization of the enterovirus 71 VP1 protein as a vaccine candidate","volume":"87","author":"Zhou","year":"2015","journal-title":"J Med Virol."},{"key":"10.1016\/j.vaccine.2015.10.103_bib0175","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1203\/01.pdr.0000238247.86041.19","article-title":"Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71","volume":"60","author":"Chang","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0180","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0264-410X(01)00385-1","article-title":"Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus","volume":"20","author":"Wu","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0185","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbrc.2012.11.035","article-title":"Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice","volume":"430","author":"Wang","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0190","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1016\/j.vaccine.2013.05.019","article-title":"Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice","volume":"31","author":"Li","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0195","doi-asserted-by":"crossref","first-page":"e46043","DOI":"10.1371\/journal.pone.0046043","article-title":"Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice","volume":"7","author":"Mao","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0200","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0205","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0210","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.vaccine.2008.03.041","article-title":"Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection","volume":"26","author":"Chen","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0022-1759(83)90308-3","article-title":"A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells","volume":"65","author":"Czerkinsky","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0220","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1128\/JVI.02358-10","article-title":"Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection","volume":"85","author":"Yamayoshi","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0225","doi-asserted-by":"crossref","first-page":"9386","DOI":"10.1128\/JVI.02856-06","article-title":"An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys","volume":"81","author":"Arita","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0230","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Roldao","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0235","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1016\/j.vaccine.2014.06.025","article-title":"A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice","volume":"32","author":"Ku","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0240","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1479-0556-5-6","article-title":"DNA vaccine constructs against enterovirus 71 elicit immune response in mice","volume":"5","author":"Tung","year":"2007","journal-title":"Genet Vaccines Ther"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0245","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.micinf.2007.06.002","article-title":"Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide","volume":"9","author":"Foo","year":"2007","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0250","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/CVI.00491-13","article-title":"Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6 to 59 months","volume":"20","author":"Hu","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0255","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/S0264-410X(03)00334-7","article-title":"Placental transport of immunoglobulin G","volume":"21","author":"Simister","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0260","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0265","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1016\/j.vaccine.2011.04.070","article-title":"Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection","volume":"29","author":"Bek","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0270","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/JVI.00999-09","article-title":"Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease","volume":"84","author":"Ong","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0275","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.vetimm.2006.02.008","article-title":"The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination","volume":"112","author":"Kitikoon","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0280","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fimmu.2014.00446","article-title":"Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies","volume":"5","author":"Niewiesk","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0285","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-3083.2009.02298.x","article-title":"Studies on the mechanism by which antigen-specific IgG suppresses primary antibody responses: evidence for epitope masking and decreased localization of antigen in the spleen","volume":"70","author":"Getahun","year":"2009","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0290","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.4049\/jimmunol.167.10.5558","article-title":"FcgammaRIIB in IgG-mediated suppression of antibody responses: different impact in vivo and in vitro","volume":"167","author":"Karlsson","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/mic.0.049601-0","article-title":"Pre-existing immunity against vaccine vectors\u2014friend or foe","volume":"159","author":"Saxena","year":"2013","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0300","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMoa0904797","article-title":"Effect of human rotavirus vaccine on severe diarrhea in African infants","volume":"362","author":"Madhi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0305","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4161\/hv.6.7.11278","article-title":"Performance of rotavirus vaccines in developed and developing countries","volume":"6","author":"Jiang","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2015.10.103_bib0310","doi-asserted-by":"crossref","first-page":"14753","DOI":"10.1073\/pnas.1217563110","article-title":"Transgenic mouse model for the study of enterovirus 71 neuropathogenesis","volume":"110","author":"Fujii","year":"2013","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T22:27:22Z","timestamp":1537223242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15015595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":31,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15015595"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.103","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}